FDA recall D-1665-2019

Product

HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC 70731-0114-95] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.

Reason for recall

Lack of Assurance of Sterility

Distribution

Nationwide USA

Key facts

Status

Terminated

Initiation date

2019-06-19

Report date

2019-08-14

Termination date

2022-09-16

Voluntary/Mandated

Voluntary: Firm initiated

Location

Athens, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1665-2019